Health and Fitness Health and Fitness
Wed, February 22, 2012
[ Wed, Feb 22nd 2012 ] - Market Wire
Paladin and Somaxon Announce Filing of New Drug Submission for Silenor(R)
[ Wed, Feb 22nd 2012 ] - Market Wire
Horizon Pharma Secures $60 Million Loan Facility
[ Wed, Feb 22nd 2012 ] - Market Wire
Amarillo Biosciences Appoints Dr. Stephen Chen as Chairman and CEO
[ Wed, Feb 22nd 2012 ] - Market Wire
Brower Piven Announces the Filing of a Class Acti .. harmaceuticals, Inc. Expanding the Class Period t
[ Wed, Feb 22nd 2012 ] - Market Wire
Onyx Pharmaceuticals Completes Enrollment in ASPI .. ation Trial for the Potential Treatment of Relaps
[ Wed, Feb 22nd 2012 ] - Market Wire
Endo Pharmaceuticals to Present at Cowen amp;; Co. 32nd Annual Health Care Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Halozyme Therapeutics to Present at the CITI 2012 Global Healthcare Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
ERT to Present at the Citi 2012 Global Health Care Conference February 29, 2012
[ Wed, Feb 22nd 2012 ] - Market Wire
Hospira to Present at the Barclays Capital Global Healthcare Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Trinity Health to Improve Revenue Cycle Through ChartMaxx Implementation
[ Wed, Feb 22nd 2012 ] - Market Wire
A&E Begins Filming An 8-episode Documentary With .. inted Director of Horticulture Bret Bogue;;
[ Wed, Feb 22nd 2012 ] - Market Wire
MIT Awarded 2012 Federal Laboratory Consortium 'Excellence in Technology Transfer Award'
[ Wed, Feb 22nd 2012 ] - Market Wire
LifePoint Hospitals to Participate in RBC Capital Marketsa 2012 Global Healthcare Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Magellan Behavioral Care of Iowa Receives Full Three-Year MBHO Accreditation from NCQA
[ Wed, Feb 22nd 2012 ] - Market Wire
Boston Scientific to Participate in 2012 RBC Capital Markets' Global Healthcare Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Hologic to Launch Four New Products at the European Congress of Radiology in Vienna
[ Wed, Feb 22nd 2012 ] - Market Wire
Critical Alerts For Pfizer, FedEx, Bristol Myers, .. , and Polypore Released By Seven Summits Research
[ Wed, Feb 22nd 2012 ] - Market Wire
ATamp;;T Selected as Carrier to Connect Bo .. vices: Offering Physician and Patient Convenience
[ Wed, Feb 22nd 2012 ] - Market Wire
AT&T Selected as Carrier to Connect Boston Scient .. vices: Offering Physician and Patient Convenience
[ Wed, Feb 22nd 2012 ] - Market Wire
Mettler-Toledo International Inc. Announces Webcast of Presentation at Citi Health Care Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Concentra Selects Allscripts Electronic Health Record for Concentra Medical Centers
[ Wed, Feb 22nd 2012 ] - Market Wire
Critical Outcome Technologies Inc. Selected for Trade Mission to BioPartnering North America
[ Wed, Feb 22nd 2012 ] - Market Wire
AVI BioPharma Regains NASDAQ Compliance
[ Wed, Feb 22nd 2012 ] - Market Wire
Novelos Therapeutics Announces Enrollment of Firs .. al With I-124-CLR1404 (Light) Cancer-Targeted PET
[ Wed, Feb 22nd 2012 ] - Market Wire
Synta Provides Clinical Update and Reports Fourth Quarter and Year End 2011 Financial Results
[ Wed, Feb 22nd 2012 ] - Market Wire
ARIAD to Present at Citi 2012 Global Health Care Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
PROLOR Biotech to Present at 2012 Citi Global Health Care Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Sequenom, Inc. Announces Date of Fourth Quarter a .. l-Year 2011 Financial Results and Conference Call
[ Wed, Feb 22nd 2012 ] - Market Wire
SciClone Pharmaceuticals to Present at RBC Capital Markets' Global Healthcare Conference
[ Wed, Feb 22nd 2012 ] - Market Wire
Isis Pharmaceuticals' 2011 Financial Results and Highlights Conference Call

Isis Pharmaceuticals' 2011 Financial Results and Highlights Conference Call


Published on 2012-02-22 04:05:56 - Market Wire
  Print publication without navigation


Webcast Alert: Isis Pharmaceuticals' 2011 Financial Results and Highlights Conference Call -- CARLSBAD, Calif., Feb. 22, 2012 /PRNewswire/ --

Webcast Alert: Isis Pharmaceuticals' 2011 Financial Results and Highlights Conference Call

[ ]

CARLSBAD, Calif., Feb. 22, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (Nasdaq: [ ISIS ]) announces the following webcast:

cellpadding="0" cellspacing="0" id="convertedTable" style="BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt; BORDER-COLLAPSE: collapse; BORDER-TOP: 1pt; BORDER-RIGHT: 1pt">

What:

Isis Pharmaceuticals' 2011 Financial Results and Highlights

When:

Wednesday, February 29, 2012 at 8:30 a.m. ET / 5:30 a.m. PT

Where:

[ www.isispharm.com ]

How:

Live on the Internet.  Simply log onto our Web site listed above.

If you are unable to participate during the live event, a replay of the webcast will be available for a limited time at [ www.isispharm.com ].

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners. Isis' broad pipeline consists of 26 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer. Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, following regulatory approval, which is expected in 2012. Isis' patents provide strong and extensive protection for its drugs and technology. Additional information about Isis is available at [ www.isispharm.com ].

SOURCE Isis Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.isispharm.com ]

Contributing Sources